INS and metabolic disease: Firstly, compared with eCO, FeNO may exhibit less involvement in metabolic pathways30, since eCO can stimulate insulin and glucagon release from islet cells as well as modulate insulin sensitivity and glucose tolerance in metabolic disorder animals29.